Francesco L Ierino
Overview
Explore the profile of Francesco L Ierino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Kausman J, Walker A, Cantwell L, Quinlan C, Sypek M, Ierino F
Pediatr Transplant
. 2016 Sep;
20(7):931-938.
PMID: 27662811
Donor-recipient HLA mismatch remains a leading cause for sensitization and graft loss in kidney transplantation. HLA compatibility at an epitope level is emerging as an improved method of matching compared...
13.
Roberts M, Pilmore H, Ierino F, Badve S, Cass A, Garg A, et al.
Am J Kidney Dis
. 2016 Jan;
67(6):902-11.
PMID: 26717861
Background: β-Blocking agents reduce cardiovascular mortality in patients with heart disease, but their potential benefit in dialysis patients is unclear. We aimed to determine the feasibility of a randomized controlled...
14.
Crawford K, Low J, Manias E, Walker R, Toussaint N, Mulley W, et al.
J Eval Clin Pract
. 2015 Sep;
21(5):879-85.
PMID: 26371625
Rationale, Aims And Objectives: Medication adherence is essential in kidney transplant recipients to reduce the risk of rejection and subsequent allograft loss. The aim of this study was to delineate...
15.
Roberts M, Pilmore H, Ierino F, Badve S, Cass A, Garg A, et al.
Nephrology (Carlton)
. 2014 Nov;
20(3):140-7.
PMID: 25382452
Aims: The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study aims to determine the feasibility of a large-scale randomized controlled trial with clinical endpoints comparing the beta-blocking agent carvedilol...
16.
Roberts M, Hare D, Sikaris K, Ierino F
Clin J Am Soc Nephrol
. 2014 Apr;
9(6):1024-32.
PMID: 24721887
Background And Objectives: B-type natriuretic peptide (BNP) concentration predicts outcome in patients undergoing dialysis. Because survival and cardiovascular risk change across the CKD continuum, serial changes in BNP were compared...
17.
Roberts M, Velkoska E, Ierino F, Burrell L
Nephrol Dial Transplant
. 2013 Mar;
28(9):2287-94.
PMID: 23535224
Background: Angiotensin-converting enzyme 2 (ACE2) is a novel regulator of the renin-angiotensin system that counteracts the adverse effects of angiotensin II. In heart failure patients, elevated plasma ACE2 activity predicted...
18.
Roberts M, Pilmore H, Tonkin A, Garg A, Pascoe E, Badve S, et al.
Am J Kidney Dis
. 2012 Jun;
60(3):463-72.
PMID: 22704141
The association between blood pressure and cardiovascular outcomes in patients undergoing hemodialysis remains controversial. This may relate in part to the technique and device used and the timing of the...
19.
Lin W, Christiansen D, Fu L, Roberts M, Sandrin M, Ierino F
Nephrology (Carlton)
. 2012 Feb;
17(4):415-22.
PMID: 22308996
Aim: Immunophenotype peripheral blood T cells from renal transplant recipients (RTR) using cellular markers of regulatory T cells (Tregs) and flow cytometry, including Foxp3, and correlate these findings with clinical...
20.
Hodgson R, Christiansen D, Ziolkowski A, Mouhtouris E, Simeonovic C, Ierino F, et al.
Transplantation
. 2011 May;
91(10):1090-7.
PMID: 21544030
Background: Blockade of the inducible costimulator (ICOS) pathway has been shown to prolong allograft survival; however, its utility in xenotransplantation is unknown. We hypothesize that local expression of ICOS-Ig by...